March 3, 2018
Healthcare: In 2016, Multiple Sclerosis (MS) disease-modifying therapies (DMTs) sales were expected to be $19.1 billion across the seven major markets (7MM*) in 2016. This continues to grow to $25.3 billion in 2026, at a CAGR of 2.9%. Multiple Sclerosis’ states that this growth will be driven by an increase in treatment rates and the introduction of numerous pipeline products offsetting the generic erosion of key brands.
The market has been dominated by four players – Biogen, Merck Serono, Teva, and Bayer HealthCare – through the commercialization of their first-line injectable DMTs. The current MS market is becoming increasingly competitive, with a large number of drugs that offer relatively good safety but only moderate efficacy.
Reliance on these platforms injectable is expected to wane over the forecast period due to the continued uptake of oral DMTs and efficacious pipeline products. “Various R&D and corporate strategies have been employed by players in order to compete effectively in the increasingly competitive MS market. The research further identifies 17 late-stage drug products that are anticipated to enter the MS market during the 10-year forecast period and collectively, these pipeline products are anticipated to claim a 29.6% share of the global MS market by 2026, generating combined sales of $7.5 billion.
These strategies include the development of products that target key clinical unmet needs or progressive types of MS, thereby expanding the coverage of marketed products, as well as strategic partnerships between companies. Despite the increasingly competitive nature of the MS market, lucrative opportunities remain for products that target unmet needs.
Targeting progressive MS will be an ongoing opportunity, as competition for market share in this segment.
Contents of the Report
- Table of Contents
- Executive Summary
- Introduction
- Disease Overview
- Epidemiology
- Disease Management
- Competitive Assessment
- Unmet Needs and Opportunity Assessment
- Pipeline Assessment
- Current and Future Players
- Market Outlook
- Appendix
Key benefits of buying this profile include:
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global MS therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global MS therapeutics market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
About GlobalData
GlobalData is a leading provider of global business intelligence including market, competitor, and product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team.
About MarketsandReports.com
MarketsandReports.com is a syndicated report platform with wide variety of industry reports from reputed industry publishers. MarketsandReports.com is promoted by DART Consulting. MarketsandReports.com lists variety of reports at the best price with seasonal discounts and promotion codes.
This report is available at www.marketsandreports.com
Contact us:
MarketsandReports.com
Direct: + 91-80- 4224 7136, 953-807- 6063
Email: sales@marketsandreports.com
Web: www.marketsandreports.com
